Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care

NARecruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

September 20, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

August 31, 2025

Conditions
Diabetic Foot UlcerDiabetic FootFoot UlcerUlcer FootDFU
Interventions
OTHER

SLAM + SOC

Weekly Treatment visits for 12 weeks begin at day 0. SLAM applications with SOC until ulcer closure, or a maximum of 12 weeks, whichever occurs first.

OTHER

SOC

Beginning at the screening visit, participants will receive weekly treatment with standard of care (cleaning, debridement, ulcer moisture balance, and offloading) until ulcer closure, or a maximum of 12 weeks, whichever occurs first.

Trial Locations (1)

48038

RECRUITING

Detroit Foot and Ankle, Clinton Township

Sponsors
All Listed Sponsors
collaborator

SerenaGroup, Inc.

NETWORK

lead

Applied Biologics, LLC

INDUSTRY

NCT06564831 - Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care | Biotech Hunter | Biotech Hunter